{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:14:37Z","timestamp":1786997677453,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.transproceed.2024.11.026","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:11:14Z","timestamp":1736007074000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Maintenance Immunosuppression With Tacrolimus and Everolimus in Heart Transplantation Compared With the Usual Tacrolimus and Micophenolate Protocol: Results From a Retrospective Registry"],"prefix":"10.1016","volume":"57","author":[{"given":"Mar\u00eda","family":"Vigil-Escalera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Catal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Herrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garc\u00eda-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Gonz\u00e1lez-Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"D\u00edaz-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.transproceed.2024.11.026_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.transproceed.2024.11.026_bib0002","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.recesp.2023.06.006","article-title":"Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology","volume":"76","author":"Gonz\u00e1lez-V\u00edlchez","year":"2023","journal-title":"Rev Espanola Cardiol Engl Ed"},{"issue":"5","key":"10.1016\/j.transproceed.2024.11.026_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant: Off Publ Int Soc Heart Transplant"},{"key":"10.1016\/j.transproceed.2024.11.026_bib0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2018.12.004","article-title":"Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated cytomegalovirus infection","volume":"162","author":"Tan","year":"2019","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.transproceed.2024.11.026_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/tid.12007","article-title":"Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation","volume":"15","author":"Kobashigawa","year":"2013","journal-title":"Transpl Infect Dis: Off J Transplant Soc"},{"issue":"9","key":"10.1016\/j.transproceed.2024.11.026_bib0006","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2024.11.026_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2015.10.082","article-title":"Suppressive effects of conversion from mycophenolate mofetil to everolimus for the development of cardiac allograft vasculopathy in maintenance of heart transplant recipients","volume":"203","author":"Watanabe","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.transproceed.2024.11.026_bib0008","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"2 Suppl. 1","key":"10.1016\/j.transproceed.2024.11.026_bib0009","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1681\/ASN.V22s45","article-title":"Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury","volume":"2","author":"Myers","year":"1991","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.transproceed.2024.11.026_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.intimp.2019.01.035","article-title":"The change of immunosuppressive regimen from calcineurin inhibitors to mammalian target of rapamycin (mTOR) inhibitors and its effect on malignancy following heart transplantation","volume":"69","author":"Saber-Moghaddam","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.transproceed.2024.11.026_bib0011","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1432-2277.2011.01247.x","article-title":"Surgical wound complications after heart transplantation","volume":"24","author":"Zuckermann","year":"2011","journal-title":"Transpl Int: Off J Eur Soc Organ Transplant"},{"issue":"7","key":"10.1016\/j.transproceed.2024.11.026_bib0012","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant: Off Publ Int Soc Heart Transplant"},{"issue":"11","key":"10.1016\/j.transproceed.2024.11.026_bib0013","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant: Off Publ Int Soc Heart Transplant"},{"issue":"8","key":"10.1016\/j.transproceed.2024.11.026_bib0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/phar.2716","article-title":"Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation","volume":"42","author":"Nelson","year":"2022","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"3","key":"10.1016\/j.transproceed.2024.11.026_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/TP.0000000000001945","article-title":"Optimizing the safety profile of everolimus by delayed initiation in de novo heart transplant recipients: results of the prospective randomized study EVERHEART","volume":"102","author":"Potena","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.11.026_bib0016","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1111\/ajt.15361","article-title":"Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study","volume":"19","author":"Barten","year":"2019","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"5","key":"10.1016\/j.transproceed.2024.11.026_bib0017","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"7","key":"10.1016\/j.transproceed.2024.11.026_bib0018","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tri.12783","article-title":"Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial","volume":"29","author":"Gullestad","year":"2016","journal-title":"Transpl Int: Off J Eur Soc Organ Transplant"},{"issue":"1","key":"10.1016\/j.transproceed.2024.11.026_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE study","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.transproceed.2024.11.026_bib0020","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.transproceed.2012.09.045","article-title":"Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients","volume":"44","author":"Kaplinsky","year":"2012","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524006717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524006717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T14:56:37Z","timestamp":1739199397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524006717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0041134524006717"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.11.026","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maintenance Immunosuppression With Tacrolimus and Everolimus in Heart Transplantation Compared With the Usual Tacrolimus and Micophenolate Protocol: Results From a Retrospective Registry","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}